Deferoxamine treatment for intracerebral hemorrhage in aged rats: Therapeutic time window and optimal duration

Stroke

Volumn 41, Issue 2, 2010, Pages 375-382

  Okauchi, Masanobu ^a   Hua, Ya ^a   Keep, Richard F ^a,b   Morgenstern, Lewis B ^a,b   Schallert, Timothy ^a,c   Xi, Guohua ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Behavior; Brain atrophy; Brain edema; Cerebral hemorrhage; Deferoxamine; Iron

Indexed keywords

DEFEROXAMINE; SIDEROPHORE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BLOOD AUTOTRANSFUSION; BRAIN ATROPHY; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN VENTRICLE DILATATION; CONTROLLED STUDY; HUMAN; MALE; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RAT; TREATMENT DURATION; TREATMENT OUTCOME; AGING; ANIMAL; ATROPHY; CAUDATE NUCLEUS; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECT; FISCHER 344 RAT; LATERAL BRAIN VENTRICLE; MENTAL DISEASE; MOTOR DYSFUNCTION; PATHOLOGY; PATHOPHYSIOLOGY; TIME; VASCULARIZATION;

AGING; ANIMALS; ATROPHY; BRAIN EDEMA; CAUDATE NUCLEUS; CEREBRAL HEMORRHAGE; DEFEROXAMINE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; LATERAL VENTRICLES; MALE; MENTAL DISORDERS; MOVEMENT DISORDERS; RATS; RATS, INBRED F344; SIDEROPHORES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77449128889     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.569830     Document Type: Article

References (24)

1. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373:1632-1644.
2. Broderick JP, Brott T, Tomsick T, Miller R, Huster G. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 1993;78:188-191.
3. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral hemorrhage. Lancet Neurol. 2006;5:53-63.
4. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke. 2003;34:2964-2969.
5. Lou M, Lieb K, Selim M. The relationship between hematoma iron content and perihematoma edema: An MRI study. Cerebrovasc Dis. 2009;27:266-271.
6. Selim M. Deferoxamine mesylate: A new hope for intracerebral hemorrhage: From bench to clinical trials. Stroke. 2009;40:S90-S91.
7. Hua Y, Keep RF, Hoff JT, Xi G. Deferoxamine therapy for intracerebral hemorrhage. Acta Neurochirurgica. 2008;105 (Suppl):3-6.
8. Nakamura T, Keep R, Hua Y, Schallert T, Hoff J, Xi G. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg. 2004;100:672-678.
9. Hua Y, Nakamura T, Keep RF, Wu J, Schallert T, Hoff JT, Xi G. Long-term effects of experimental intracerebral hemorrhage: The role of iron. J Neurosurg. 2006;104:305-312.
10. Song S, Hua Y, Keep RF, Hoff JT, Xi G. A new hippocampal model for examining intracerebral hemorrhage-related neuronal death: Effects of deferoxamine on hemoglobin-induced neuronal death. Stroke. 2007;38: 2861-2863.
11. Gu Y, Hua Y, Keep RF, Morgenstern LB, Xi G. Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke. 2009;40:2241-2243.
12. Okauchi M, Hua Y, Keep RF, Morgenstern LB, Xi G. Effects of defer-oxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke. 2009;40:1858-1863.
13. Xi G, Keep RF, Hoff JT. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg. 1998;89: 991-996.
14. Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G. Behavioral tests after intracerebral hemorrhage in the rat. Stroke. 2002;33:2478-2484.
15. Porter JB. Deferoxamine pharmacokinetics. Semin Hematol. 2001; 38(Suppl 1):63-68.
16. Suzuki J, Ebina T. Sequential changes in tissue surrounding ICH. Spontaneous intracerebral hematomas. In: Pia HW, Longmaid C, Zierski J, eds. Berlin: Springer; 1980:121-128.
17. Wagner KR, Xi G, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE, Broderick JP, Brott TG. Lobar intracerebral hemorrhage model in pigs: Rapid edema development in perihematomal white matter. Stroke. 1996;27:490-497.
18. Ropper AH. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N Engl J Med. 1986;314: 953-958.
19. Enzmann DR, Britt RH, Lyons BE, Buxton JL, Wilson DA. Natural history of experimental intracerebral hemorrhage: Sonography, computed tomography and neuropathology. AJNR Am J Neuroradiol. 1981;2: 517-526.
20. Tomita H, Ito U, Ohno K, Hirakawa K. Chronological changes in brain edema induced by experimental intracerebral hematoma in cats. Acta Neurochir. 1994;60 (Suppl):558-560.
21. Huang F, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT. Brain edema after experimental intracerebral hemorrhage: Role of hemoglobin degradation products. J Neurosurg. 2002;96:287-293.
22. Wagner KR, Xi G, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE. Early metabolic alterations in edematous perihematomal brain regions following experimental intracerebral hemorrhage. J Neurosurg. 1998;88:1058-1065.
23. Du C, Hu R, Hsu CY, Choi D. Dextrorphan reduces infarct volume, vascular injury, and brain edema after ischemic brain injury. J Neurotrauma. 1996; 13:215-222.
24. Ginsberg MD. Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology. 2008;55:363-389.